Hikma Pharmaceuticals Says FDA Lifts Warning On Eatontown Facility

Hikma Pharmaceuticals Plc said on Wednesday that the U.S. Food and Drug Administration had lifted the warning on its Eatontown facility in New Jersey where it makes oral products for the U.S. market. The Jordanian company, which makes and markets branded and non-branded generics and injectibles, said it was gradually reintroducing products to the U.S. market from the facility. The company had suspended manufacturing at the plant in 2012 after receiving an FDA warning letter.

Help employers find you! Check out all the jobs and post your resume.